* Impacts only claims paid by the Vendor Drug Program: traditional Medicaid, CSHCN, HTW, and KHC Programs. † To learn about traditional Medicaid claim pricing and PPG pricing incentives please refer to the Drug Pricing & Reimbursement (PDF) chapter of the VDP Pharmacy Provider Procedure Manual. ‡ Please review the lists of DUR board-approved clinical prior authorizations that apply to traditional Medicaid and those that health plans may use. The Pharmacy Clinical Prior Authorization Assistance Chart (PDF) shows the prior authorization each health plan uses and how those authorizations relate to the authorizations used for traditional Medicaid claim processing. Refer to the MCO Resources for links to each health plan's active clinical prior authorizations. Β-lactamase−producing strains of Haemophilus influenzae and Moraxella catarrhalis Mild to moderate: 500/125 mg PO q12hr or 250/125 mg PO q8hr for 10 days Severe: 875/125 mg PO q12hr or 500/125 mg PO q8hr or 2000 mg (2 extended-release tabs) PO q12hr for 7-10 days Take with meals to avoid GI upset Take suspension at start of meal to enhance absorption Dysphagia: May substitute 250 mg/5 m L suspension for 500/125 mg tablet; may substitute 200 mg/5 m L or 400 mg/5 m L suspension for 875/125 mg tablet Because of the different amoxicillin-to-clavulanate ratios in the 250-mg tablet (amoxicillin 250 mg, clavulanate125 mg) and the 250-mg chewable tablet (amoxicillin 250 mg, clavulanate 62.5 mg), the 250-mg tablet should not be used if the pediatric patient weighs Hypersensitivity reactions Anaphylaxis Anemia Thrombocytopenia Leukopenia Agranulocytosis Hepatoxicity AST/ALT elevation Pseudomembranous colitis Serum sickness Abdominal discomfort Cholestatic jaundice Flatulence Allergy to cephalosporins, carbapenems Different tablets are not interchangeable, because ratios of amoxicillin to clavulanate are different Extended release tablets not for use in renal impairment (Cr Cl Amoxicillin binds to penicillin-binding proteins, thus inhibiting final transpeptidation step of peptidoglycan synthesis in bacterial cell walls; addition of clavulanate inhibits beta-lactamase-producing bacteria, allowing amoxicillin extended spectrum of action It is a semisynthetic antibiotic with a broad spectrum of bactericidal activity, covering both gram-negative and gram-positive microorganisms Not effective against Mycoplasma and Legionella spp Peak plasma time: 2 hr (amoxicillin); 1.1 hr (clavulanic acid) Peak concentration: 8-22 mcg/m L (amoxicillin); 0.8-2.6 mcg/m L (clavulanic acid) AUC: 40-80 mcg•hr/m L (amoxicillin); 2-6 mcg•hr/m L (clavulanic acid) The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information. Nolvadex ebay Cialis side effects eyes Buy viagra in sharm el sheikh Consumer information about the medication AMOXICILLIN TABLET 875 MG - ORAL Amoxil, includes side effects, drug interactions, recommended dosages, and storage information. Read more about the prescription drug AMOXICILLIN TABLET 875 MG - ORAL. For a more severe infection, a common dose of amoxicillin is 875 mg every 12 hours or 500 mg every 8 hours. A common dose of amoxicillin for a child older than 3 months with a lower respiratory. Amoxicillin as amoxicillin trihydrate 875 MG / clavulanic acid as clavulanate potassium 125 MG Oral Tablet. ID. This website contains 106190 drug listings as submitted to the Food and Drug Administration (FDA). At the present time, this Web site does not contain a complete listing of labels for approved prescription drugs. Posted: December 19, 2017 Drug Listing Certification The U. Food and Drug Administration is reminding the pharmaceutical industry of the December 31, 2017, deadline to update or certify their drug listings with FDA. This applies to drug listings that were not initially listed or updated during the current calendar year. This is the first deadline of the annual certification requirement under Part 207 of Title 21 of the Code of Federal Regulations. Companies must submit this information to FDA in electronic format. They may make a blanket "no changes" certification to indicate that their listing information is up to date in FDA's database. Augmentin contains two drugs: amoxicillin and clavulanic acid. Augmentin belongs to the penicillin class of antibiotics. This combination makes Augmentin work against more types of bacteria than antibiotics that contain amoxicillin alone. Augmentin is effective for treating infections caused by many different types of bacteria. These include bacteria that cause: Augmentin is available in a generic form. The generic name of Augmentin is amoxicillin/clavulanate potassium. Generic drugs are often less expensive than the brand-name version. Amoxicillin 875 Augmentin Side Effects, Dosage, Uses, and More - Healthline, Amoxicillin - Diflucan duoTamoxifen vs raloxifeneFluconazole lactationXanax necklaceBuy kamagra soho london Tablets Each tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Each film-coated, capsule-shaped, pink tablet is debossed with AMOXIL centered. Amoxicillin Amoxil Drug Side Effects, User Reviews, Drug. - RxList. RxNORM - Amoxicillin 875 MG / Clavulanate 125 MG Oral Tablet.. AMOXICILLIN 875 MG TABLET Vendor Drug Program. Each tablet contains 500 mg or 875 mg amoxicillin as the trihydrate and 125 mg clavulanic acid as the potassium salt. Each amoxicillin and clavulanate. Amoxicillin 875 mg Tablets Amoxicillin Amoxil ® is an antibiotic approved for treating a wide variety of different infections. It is available by prescription only. Amoxicillin 875 mg tablet. color pink shape oblong imprint WW 951 This medicine is a pink, oblong, scored, film-coated, tablet imprinted with "WW 951". ‹ Back to Gallery. amoxicillin 500 mg tablet.